Syndrome of Inappropriate Antidiuretic Hormone in a Patient Receiving High-Dose Haloperidol and Quetiapine Therapy.
Dept. of Pharmacy, Wake Forest Baptist Medical Center, Winston-Salem, NC (MTK); and the Depts. of Pharmaceutical Services (SEH), Anesthesiology (SST), and Trauma and Surgical Critical Care (ODG), Vanderbilt University Medical Center, Nashville, TN.
Michael T
MT
Kenes
Dept. of Pharmacy, Wake Forest Baptist Medical Center, Winston-Salem, NC (MTK); and the Depts. of Pharmaceutical Services (SEH), Anesthesiology (SST), and Trauma and Surgical Critical Care (ODG), Vanderbilt University Medical Center, Nashville, TN.
Susan E
SE
Hamblin
Dept. of Pharmacy, Wake Forest Baptist Medical Center, Winston-Salem, NC (MTK); and the Depts. of Pharmaceutical Services (SEH), Anesthesiology (SST), and Trauma and Surgical Critical Care (ODG), Vanderbilt University Medical Center, Nashville, TN.
Srinivas S
SS
Tumuluri
Dept. of Pharmacy, Wake Forest Baptist Medical Center, Winston-Salem, NC (MTK); and the Depts. of Pharmaceutical Services (SEH), Anesthesiology (SST), and Trauma and Surgical Critical Care (ODG), Vanderbilt University Medical Center, Nashville, TN.
Oscar D
OD
Guillamondegui
D000328:Adult; D006220:Haloperidol / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007177:Inappropriate ADH Syndrome / Q000139:chemically induced*; D008297:Male; D011595:Psychomotor Agitation / Q000188:drug therapy*; D000069348:Quetiapine Fumarate / Q000009:adverse effects* / Q000627:therapeutic use
D000069348:Quetiapine Fumarate; D006220:Haloperidol